Javascript must be enabled to continue!
Differential Host Gene Signatures in Response to Mycobacterium tuberculosis Infection
View through CrossRef
ABSTRACT
Tuberculosis (TB) represents a global public health threat and is the leading cause of morbidity and mortality worldwide. Effective control of TB is complicated with the emergence of multidrug resistance. Yet, there is still a fundamental gap in understanding the complex and dynamic interactions between different
Mycobacterium tuberculosis
strains and the host. In this project, we investigated the host immune response to different
M. tuberculosis
strains, including avirulent or virulent and rifampin-resistant or isoniazid-resistant strains in THP-1 cells. We identified major differences in the gene response profiles in response to infection with these strains. The expression of IDO1 and IL-1β in the infected cells was stronger in all virulent
M. tuberculosis
strains. The most striking result was the overexpression of many interferon-stimulated genes (ISGs) in cells infected with the isoniazid-resistant strain, compared to the rifampin-drug resistant strain and the drug-sensitive strain. A transcription regulation analysis of the differentially expressed genes in infected THP-1 cells implicated two major transcription factors, NF-κB and STAT1. The differentially expressed ISGs in response to the isoniazid-resistant
M. tuberculosis
strain were associated with STAT1 signaling, while the expression of many cytokines, such IL-1β, was associated with NF-κB signaling. Our data suggest that the isoniazid-resistant
M. tuberculosis
strain preferentially activates STAT1 in response to cGAS-STING activation and induces a host immune response signature that is characteristic of isoniazid resistance. This study has a potential to provide important new insights into TB pathogenesis and to characterize host gene signatures specifically involved in isoniazid-resistant TB.
Title: Differential Host Gene Signatures in Response to
Mycobacterium tuberculosis
Infection
Description:
ABSTRACT
Tuberculosis (TB) represents a global public health threat and is the leading cause of morbidity and mortality worldwide.
Effective control of TB is complicated with the emergence of multidrug resistance.
Yet, there is still a fundamental gap in understanding the complex and dynamic interactions between different
Mycobacterium tuberculosis
strains and the host.
In this project, we investigated the host immune response to different
M.
tuberculosis
strains, including avirulent or virulent and rifampin-resistant or isoniazid-resistant strains in THP-1 cells.
We identified major differences in the gene response profiles in response to infection with these strains.
The expression of IDO1 and IL-1β in the infected cells was stronger in all virulent
M.
tuberculosis
strains.
The most striking result was the overexpression of many interferon-stimulated genes (ISGs) in cells infected with the isoniazid-resistant strain, compared to the rifampin-drug resistant strain and the drug-sensitive strain.
A transcription regulation analysis of the differentially expressed genes in infected THP-1 cells implicated two major transcription factors, NF-κB and STAT1.
The differentially expressed ISGs in response to the isoniazid-resistant
M.
tuberculosis
strain were associated with STAT1 signaling, while the expression of many cytokines, such IL-1β, was associated with NF-κB signaling.
Our data suggest that the isoniazid-resistant
M.
tuberculosis
strain preferentially activates STAT1 in response to cGAS-STING activation and induces a host immune response signature that is characteristic of isoniazid resistance.
This study has a potential to provide important new insights into TB pathogenesis and to characterize host gene signatures specifically involved in isoniazid-resistant TB.
Related Results
Immune mechanisms controlling tuberculosis-diabetes co-morbidity
Immune mechanisms controlling tuberculosis-diabetes co-morbidity
<p dir="ltr">Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis (M. tuberculosis), remains a leading global health concern, responsible for millions of inf...
Immune mechanisms controlling tuberculosis-diabetes co-morbidity
Immune mechanisms controlling tuberculosis-diabetes co-morbidity
<p dir="ltr">Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis (M. tuberculosis), remains a leading global health concern, responsible for millions of inf...
Trend of pulmonary tuberculosis and rifampicin-resistance among tuberculosis presumptive patients in Central Tigray, Ethiopia; 2018 -2023: a six-year retrospective study
Trend of pulmonary tuberculosis and rifampicin-resistance among tuberculosis presumptive patients in Central Tigray, Ethiopia; 2018 -2023: a six-year retrospective study
Abstract
Background
Tuberculosis (TB) is a major public health concern in the developing countries. Moreover, the emergence of multidrug-resistant t...
Trends in Mycobacterium Tuberculosis and prevalence of Rifampicin Resistance in Eastern zone, Tigray Region, Northern Ethiopia
Trends in Mycobacterium Tuberculosis and prevalence of Rifampicin Resistance in Eastern zone, Tigray Region, Northern Ethiopia
Abstract
Background Tuberculosis (TB) is an infectious disease usually caused by Mycobacterium tuberculosis (MTB) bacteria. The emergence of Mono or multidrug-resistant tub...
Trends of Mycobacterium Tuberculosis and Rifampicin resistance in Adigrat General Hospital, Eastern zone, Tigray Region, Northern Ethiopia
Trends of Mycobacterium Tuberculosis and Rifampicin resistance in Adigrat General Hospital, Eastern zone, Tigray Region, Northern Ethiopia
Abstract
Background: Tuberculosis is an infectious disease usually caused by Mycobacterium tuberculosis bacteria. The global emergence of mono- or multidrug-resistant tuber...
Trends of Mycobacterium Tuberculosis and rifampicin Resistance in Adigrat General Hospital, Eastern zone of Tigrai, North Ethiopia
Trends of Mycobacterium Tuberculosis and rifampicin Resistance in Adigrat General Hospital, Eastern zone of Tigrai, North Ethiopia
Abstract
Background: Tuberculosis is an infectious disease usually caused by Mycobacterium tuberculosis bacteria. The global emergence of mono- or multidrug-resistant tuber...
Trends of Mycobacterium Tuberculosis and rifampicin resistance in Adigrat General Hospital, Eastern Zone of Tigrai, North Ethiopia
Trends of Mycobacterium Tuberculosis and rifampicin resistance in Adigrat General Hospital, Eastern Zone of Tigrai, North Ethiopia
Abstract
Background: Tuberculosis is an infectious disease usually caused by Mycobacterium tuberculosis bacteria. The global emergence of mono- or multidrug-resistant tuber...
PRIORIZAÇÃO IN SILICO DE MOLÉCULAS COM AÇÃO SOBRE M. tuberculosis PANTOTENATO SINTETASE
PRIORIZAÇÃO IN SILICO DE MOLÉCULAS COM AÇÃO SOBRE M. tuberculosis PANTOTENATO SINTETASE
Tuberculose é uma doença infecciosa causada pelo Mycobacterium tuberculosis que continua sendo uma das principais causas de morte por doença infecciosa. Este estudo teve como objet...

